Consulting and Separation AgreementConsulting and Separation Agreement • January 25th, 2021 • Kaleido Biosciences, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Consulting and Separation Agreement (the “Agreement”), made as of January 25, 2021 is entered into by Kaleido BioSciences, Inc., a Delaware corporation with offices at 65 Hayden Aveenue, Lexington MA 02421 (the “Company”), and Katharine Knobil, M.D. an individual residing in Pennsylvania (the “Consultant”).
